Merck & Co., Inc.
MRK
Peringkat dalam Saham
#37
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Harga Saham
$148.36
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$366.03B
Perubahan (1 hari)
3.31%
Perubahan (1 tahun)
69.32%
Negara
US
Perdagangan Merck & Co., Inc. (MRK)
Kategori
Healthcare
Pendapatan untuk Merck & Co., Inc. (MRK)
Pendapatan pada Jun 2026 TTM: $66.40B
Menurut laporan keuangan terbaru dari Merck & Co., Inc., pendapatan saat ini (TTM) adalah $66.40B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $64.17B peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $60.12B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Merck & Co., Inc. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $66.40B | 2.14% |
| 2025 | $65.01B | 1.31% |
| 2024 | $64.17B | 6.74% |
| 2023 | $60.12B | 1.40% |
| 2022 | $59.28B | 21.72% |
| 2021 | $48.70B | 17.31% |
| 2020 | $41.52B | 6.13% |
| 2019 | $39.12B | -7.50% |
| 2018 | $42.29B | 5.41% |
| 2017 | $40.12B | 0.79% |
| 2016 | $39.81B | 0.78% |
| 2015 | $39.50B | -6.48% |
| 2014 | $42.24B | -4.08% |
| 2013 | $44.03B | -6.84% |
| 2012 | $47.27B | -1.62% |
| 2011 | $48.05B | 4.48% |
| 2010 | $45.99B | 67.66% |
| 2009 | $27.43B | 15.00% |
| 2008 | $23.85B | -1.44% |
| 2007 | $24.20B | 6.90% |
| 2006 | $22.64B | 2.84% |
| 2005 | $22.01B | -4.18% |
| 2004 | $22.97B | 2.17% |
| 2003 | $22.49B | 4.85% |
| 2002 | $21.45B | 1.16% |
| 2001 | $21.20B | -47.48% |
| 2000 | $40.36B | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $79.67B | 19.98% |
US
|
|
| $99.34B | 49.60% |
US
|
|
| $64.39B | -3.03% |
US
|
|
| $77.52B | 16.74% |
CH
|
|
| $56.26B | -15.27% |
CH
|
